Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway

Srdjan Grusanovic1,2,3, Petr Danek1, Maria Kuzmina1,2

  • 1Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.

EMBO Reports
|November 7, 2022
PubMed

Insights

Chronic inflammation impairs hematopoietic stem cell (HSC) function by altering their gene expression and inflammatory profile. Stat3 pathway inhibition rescues HSC fitness, offering potential therapeutic targets.

Area of Science:

  • Hematology
  • Immunology
  • Stem Cell Biology

Background:

  • Chronic inflammation poses significant health risks, impacting various tissues and organs.
  • Emerging evidence links chronic inflammation to altered hematopoiesis, but the precise mechanisms affecting hematopoietic stem cells (HSCs) remain unclear.

Purpose of the Study:

  • To investigate the mechanistic effects of chronic inflammation on HSCs using a mouse model.
  • To identify key molecular mediators and signaling pathways involved in inflammation-induced HSC dysfunction.

Main Methods:

  • Utilized a mouse model of chronic multifocal osteomyelitis (CMO) to induce sustained inflammation.
  • Analyzed hematopoietic and non-hematopoietic bone marrow compartments for HSC alterations.
  • Assessed HSC function, gene expression profiles, and inflammatory markers.
  • Investigated the role of Interleukin-6 (IL-6) and the Janus kinase/Signal transducer and activator of transcription 3 (Jak/Stat3) signaling pathway.

Main Results:

  • CMO induced HSC expansion and impaired function, with contributions from both hematopoietic and non-hematopoietic bone marrow cells.
  • The CMO environment imprinted a myeloid gene signature and pro-inflammatory profile onto HSCs.
  • IL-6 and Stat3 were identified as critical mediators; IL-6 and Stat3 blockage reduced HSC numbers.
  • Only Stat3 activity inhibition significantly restored HSC fitness, decoupling it from typical osteomyelitis features.

Conclusions:

  • Chronic inflammation detrimentally affects HSC function and number through mechanisms involving IL-6 and Stat3 signaling.
  • Targeting the Stat3 pathway holds promise for rescuing HSC fitness in inflammatory conditions.
  • These findings open new therapeutic avenues for treating stem cell dysfunction in chronic inflammatory diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
4.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K